Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Supreme Court to review Oklahoma execution procedure

Published 01/23/2015, 06:58 PM
Updated 01/23/2015, 06:58 PM
© Reuters. The United States Supreme Court is seen at sunset in Washington

By Lawrence Hurley

WASHINGTON (Reuters) - The Supreme Court on Friday agreed to review Oklahoma's controversial method of execution by lethal injection, taking up a case brought by three death row inmates who accuse the state of violating the U.S. Constitution's ban on cruel and unusual punishment.

The high court just last week allowed the execution of a convicted killer in Oklahoma over the objection of its four liberal members.

The three-drug process used by Oklahoma prison officials has been under scrutiny since the April 2014 botched execution of convicted murderer Clayton Lockett. He could be seen twisting on the gurney after death chamber staff failed to place the IV properly.

The inmates challenging the state's procedures argue the sedative used by Oklahoma, midazolam, cannot achieve the level of unconsciousness required for surgery, making it unsuitable for executions.

The case draws fresh attention to the ongoing debate over whether the death penalty should continue in the United States at a time when most developed countries have abandoned it.

The Death Penalty Information Center, which compiles execution statistics, says only seven of the 32 states that still have the death penalty on the books executed inmates in 2014, with most coming in just three states: Texas, Missouri and Florida. The group also says the number of executed inmates has hit a 20-year low.

The Supreme Court case directly affects only Oklahoma. But Florida uses a similar protocol so death row inmates there may seek stays based on the pending case.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On Jan. 15, the high court on a 5-4 vote declined to halt Oklahoma's execution of Charles Warner, convicted of raping and murdering an 11-month-old baby.

Although five votes are needed to grant a stay application, only four are required for the court to take up a case.

The inmates say Oklahoma's three-drug protocol can cause extreme pain, violating the Constitution's Eighth Amendment prohibition on cruel and unusual punishment.

After Lockett's execution, Oklahoma revised its protocols by increasing the amount of midazolam used to render an inmate unconscious. Lower courts endorsed the change, as did the divided Supreme Court.

Justice Sonia Sotomayor, one of the liberals who dissented in Warner's case, wrote an opinion at the time saying she was "deeply troubled by this evidence suggesting that midazolam cannot be constitutionally used as the first drug in a three-drug lethal injection protocol."

But the fact that none of the court's five conservatives, including regular swing vote Anthony Kennedy, voted to grant the stay application suggests the inmates face an uphill battle to win their case.

The inmates want the court to decide whether its 2008 Baze v. Rees ruling upholding Kentucky's three-drug execution protocol applies to Oklahoma's procedures. The inmates' lawyers say Oklahoma's protocol is different, so the reasoning of the 2008 ruling should not apply.

"The drug protocol used in Oklahoma is not capable of producing a humane execution, even if it is administered properly," said Dale Baich, an attorney for the inmates.

Oklahoma Attorney General Scott Pruitt said, "We will continue to defend the constitutionality of this protocol in order to preserve (the Department of Corrections') ability to proceed with the sentences that were given to each inmate by a jury of their peers."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The inmates are Richard Glossip, John Grant and Benjamin Cole. Glossip, who arranged for his employer to be beaten to death, is scheduled to be executed on Jan. 29. Grant, who stabbed a correctional worker to death, is due to be executed on Feb. 19. Cole, convicted of killing his 9-month-old daughter, is scheduled for execution on March 5.

The case will be argued in April, with a decision due by the end of June.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.